Px Pulse

Px Pulse
  • 5.0 (10)
  • SCIENCE
  • UPDATED BIMONTHLY
Px Pulse

Px Pulse explores vital topics confronting the field of HIV prevention research. Our monthly podcast will deepen your knowledge and help you “check the pulse” of this fast-paced field and the urgent challenges still ahead. Tune in for interviews, first-person accounts and robust discussion from advocates, researchers, policy-makers and community stakeholders as they take on critical issues facing HIV prevention research today.

  1. Community-Led Monitoring: Transforming the HIV response in Malawi

    JAN 15

    Community-Led Monitoring: Transforming the HIV response in Malawi

    Community-Led Monitoring has been on the rise in the HIV response. Known as CLM for short, it’s a tactic being championed and implemented to ensure that communities play a direct role in monitoring and improving HIV services. This episode of PxPulse: The Advocacy Chronicles puts a spotlight on CLM in Malawi, where civil society and communities are successfully using CLM to connect government decision makers to gaps in HIV services and to what people really need. Thanks to persistent advocacy, both PEPFAR and Global Fund now recognize, through their funding, the critical role of CLM. David Kamkwamba, a journalist and health advocate and the former chair of the Civil Society Advocacy Forum on HIV and related diseases (CSAF),  tells us what advocates have accomplished in Malawi and just how they did it. CSAF and AVAC are partners in the Coalition to Build Momentum, Power, Activism, Strategy & Solidarity (COMPASS) which has supported extensive work on community-led monitoring in Malawi and across the region.

    20 min
  2. An Advocacy Chronicle on Universal Healthcare in Tanzania, with Atuswege Mwangomale of Sikika

    12/12/2024

    An Advocacy Chronicle on Universal Healthcare in Tanzania, with Atuswege Mwangomale of Sikika

    In this episode of PxPulse:The Advocacy Chonicles, Atuswege Mwangomale goes deep on the advocacy work behind the passage of Tanzania’s Universal Healthcare Law. Atu serves as Head of Health Programs for Sikika, a Tanzania-based advocacy organization with a long track record of promoting best practices in governmental financing in the health sector, and advocating for improved health outcomes. Sikika, along with AVAC, is also a member of the COMPASS coalition, which uses data and coalitions across Africa to identify strategic campaigns to advance the HIV response.  Sikika’s advocacy has been crucial to the ultimate passage of Tanzania’s Universal Health Insurance Bill in 2023, but full funding must still be secured for the law to achieve full impact.   Atu explains the promise of UHC in Tanzania, how Sikika won the trust of government allies, and why working in coalition was essential to success.

    13 min
  3. The Votes Are In: What’s next for the US’ role in global health and HIV prevention? KFF’s Jen Kates and AVAC’s Suraj Madoori lay out the challenges and the priorities in 2025 and beyond.  

    11/14/2024

    The Votes Are In: What’s next for the US’ role in global health and HIV prevention? KFF’s Jen Kates and AVAC’s Suraj Madoori lay out the challenges and the priorities in 2025 and beyond.  

    In the days and years ahead under a Trump Administration, advocacy for choice, freedom, science, and rights will require deep strategic shifts to protect hard-fought gains in global health generally, and to safeguard policies and programs that advance it. And there will be major implications for the global AIDS response. Joining us to navigate all this and to better understand the landscape for advocacy are Jen Kates from KFF, a nonpartisan health policy research organization, and our own Suraj Madoori.

    21 min
  4. PxPulse: The Advocacy Chronicles with Danielle Campbell from PrEP in Black America

    10/24/2024

    PxPulse: The Advocacy Chronicles with Danielle Campbell from PrEP in Black America

    In this episode of the Advocacy Chronicles, we put the spotlight on the US, on the dismal statistics on access to PrEP in Black communities, on the state of HIV prevention among Black Americans overall, and the work of one advocacy group—PrEP in Black America (PIBA). Danielle Campbell is one of the founders of PIBA and a long-time advocate for HIV prevention and health equity. She joins the Advocacy Chronicles to talk about PIBA’s call to action for an HIV research agenda that prioritizes the needs of Black communities.

    15 min
  5. Lenacapavir: The case for investing in delivering HIV prevention

    09/19/2024

    Lenacapavir: The case for investing in delivering HIV prevention

    The promise of long-acting PrEP has been super-charged this year by studies showing the powerful efficacy of an antiretroviral known as lenacapavir (LEN).  This episode of PxPulse goes deep on LEN for PrEP. Recorded just days before Gilead’s announcement that PURPOSE 2 also found very high efficacy, Dr. Flavia Kiweewa, a principal investigator of PURPOSE 1, the first trial to announce efficacy, lays out the research findings and what they mean. And Chilufya Kasanda Hampongo of Zambia’s Treatment Advocacy and Literacy Campaign and Mitchell Warren of AVAC talk about how to change a long history of squandered opportunities to get rollout right.  The PURPOSE1 trials announced findings in June that a twice-yearly injection of LEN was 100% effective among cisgender women, with zero new cases of HIV. And the PURPOSE 2 trial among cisgender men, and trans and non-binary people, was shown to reduce the risk of HIV by 96%.  LEN now enters a select category, one of five ARV-based options for PrEP that all protect against HIV if you take them.  But many of the people applauding the results from PURPOSE 1 and 2 will tell you that breakthrough science like this is, as hard as it is, is still the easy part. To break the back of the HIV epidemic demands overcoming an altogether different challenge—coordinating and accelerating every step in rolling out new products so that everyone who needs HIV prevention can get it.    Listen to this podcast to learn what must be done to finally deliver on the promise of highly effective HIV prevention, from pills to rings to injectable PrEP and beyond.   Resources  Second Pivotal Trial of Twice-Yearly HIV Prevention Injection Safe and Highly Effective: PURPOSE 2 Trial Among Gay Men, Trans and Nonbinary People, AVAC Press Release  The Lens on LEN: The basics on injectable lenacapavir as PrEP, AVAC  Country planning matrix, PrEPWatch  Moving a Product to the Real World, AVAC  The long wait for long-acting HIV prevention and treatment formulations, Lancet  A game-changer for PrEP if access is adequate, Lancet  Allocation of Non-Commercial CAB for PrEP Supply in Low- and Middle-Income Countries, 2023-2025, AVAC  Generic Cabotegravir Timelines, AVAC  UNAIDS Exec Summary, UNAIDS  Lenacapavir: What it would it take to get the 6-monthly anti-HIV jab to SA, Bhekisisa

    32 min
  6. An Advocacy Chronicle on U=U in SA with Mandisa Dukashe

    08/29/2024

    An Advocacy Chronicle on U=U in SA with Mandisa Dukashe

    A list of tactics proved critical; establishing a dedicated working group that brought in diverse expertise and support; ensuring there were educated and committed policy leaders in government; and supporting community members to be ready to lead. Additional Resources to inform your advocacy: 1. Implementing and Scaling Up U=U: A Resource Guide chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://jasem.chiachoob.com/global-hiv-tb/media/pdfs/2024/07/U-U-Resource-Guide-July-12-2024.pdf 2. Treatment saves lives, and prevents HIV transmission https://avac.org/prevention-option/treatment/ 3. HIV Testing for Advocates https://avac.org/resource/hiv-testing-for-advocates/ 4. Prevention Access Campaign https://preventionaccess.com/ 5. WHO guidance on HIV viral suppression and scientific updates released at IAS 2023 https://www.who.int/news/item/23-07-2023-new-who-guidance-on-hiv-viral-suppression-and-scientific-updates-released-at-ias-2023

    12 min
  7. The Advocacy Chronicles with Ruth Akulu

    07/18/2024

    The Advocacy Chronicles with Ruth Akulu

    On this episode of the Advocacy Chronicles:  A look at advocacy in Uganda for the Dual Prevention Pill (DPP), a new product combining oral PrEP and oral contraception. Ruth Akulu is a member of the DPP Civil Society Advisory Group, part of the Uganda Country Coordinating Mechanism Board for Global Fund,  and a 2022 AVAC Advocacy Fellow. Akulu talks about her work to mobilize regulatory authorities to prepare for the DPP. And while she was at it, the establishment of a groundbreaking new initiative, the Product Regulator’s Engagement Committee, which is supporting ongoing engagement between government regulators and young women representing their communities.  To support your advocacy for the DPP and other multipurpose prevention technologies check out AVAC's Advocates' Guide on MPTs  https://avac.org/resource/advocates-guide-to-multipurpose-prevention-technologies-mpts/ ]

    11 min
  8. PxPulse: The Advocacy Chronicles with SMUG’s Allan Mwasa

    06/06/2024

    PxPulse: The Advocacy Chronicles with SMUG’s Allan Mwasa

    In this episode,  Nsubuga Allan Mwasa a Ugandan activist, a clinical psychologist,  and a representative of Sexual Minorities Uganda, or SMUG, an organization that has been at the forefront of the fight for LGBTQ rights, talks about how advocates are organizing to survive and challenge Uganda's Anti-Homosexuality Act (AHA), passed one year ago.  A donation to SMUG supports the work of the Strategic Response Team documenting civil rights violations and intensifying persecution of LGBTQI+ Ugandans. Funds have reached a critical low,  click here to donate to SMUG.    SMUG is part of Convening For Equality CFE, a coalition of civil society groups dedicated to challenging Uganda's AHA and other legislation that discriminates against LGBTQI+ individuals. The law has significantly increased discrimination and violence against the LGBTQI+ community, despite widespread international condemnation and ongoing legal challenges. A new report by the CFE's Strategic Response Team (SRT), UNWANTED, OUTLAWED AND ILLEGAL: THE CRY OF LGBTIQ+ UGANDANS, documents evictions, arrests, imprisonment, forced anal examaminations, and community violence against LGBTQ+ people since the passage of AHA.

    16 min
See All (48)

    Ratings & Reviews

    5
    out of 5
    10 Ratings

    About

    Px Pulse explores vital topics confronting the field of HIV prevention research. Our monthly podcast will deepen your knowledge and help you “check the pulse” of this fast-paced field and the urgent challenges still ahead. Tune in for interviews, first-person accounts and robust discussion from advocates, researchers, policy-makers and community stakeholders as they take on critical issues facing HIV prevention research today.

    Information

    • Creator
      Px Pulse
    • Years Active
      2012 - 2025
    • Episodes
      48
    • Rating
      Clean
    • Copyright
      © AVAC.org
    • Show Website
      Px Pulse

    You Might Also Like

    Content Restricted

    This episode can’t be played on the web in your country or region.

    To listen to explicit episodes, sign in.

    Stay up to date with this show

    Sign in or sign up to follow shows, save episodes, and get the latest updates.
    Select a country or region

    Africa, Middle East, and India

    Asia Pacific

    Europe

    Latin America and the Caribbean

    The United States and Canada